Bardet–Biedl Syndrome (BBS)

Bardet–Biedl syndrome (BBS) is a rare, inherited disorder that affects many parts of the body. It belongs to a group of conditions called ciliopathies, in which tiny, hair-like structures on cells (cilia) do not work properly. This ciliary dysfunction underlies the wide range of features seen in BBS, from vision loss to kidney problems and developmental delays NCBIrarediseases.info.nih.gov.

Bardet-Biedl Syndrome (BBS) is a rare, inherited ciliopathy—a disorder of the tiny “antennae” (cilia) on cells—that affects multiple organ systems. It typically manifests in early childhood with progressive vision loss (rod-cone dystrophy), extra fingers or toes (postaxial polydactyly), central obesity, learning difficulties, genital abnormalities, and kidney defects. Because the proteins encoded by at least 24 BBS genes form the “BBSome” complex critical for intraflagellar transport, mutations disrupt cilia function throughout the body, leading to the wide range of symptoms seen in BBS patients NCBIWikipedia.

People with BBS typically present in childhood. The most consistent finding is progressive retinal cone-rod dystrophy, which leads to night blindness and tunnel vision. Many also develop extra fingers or toes (postaxial polydactyly), central obesity, low sex hormone levels (hypogonadism), kidney malformations, and learning or developmental challenges MedlinePlusWikipedia. Because these features can vary even among family members, diagnosis often requires a combination of clinical examination and genetic testing.

Types of Bardet–Biedl Syndrome

BBS is genetically heterogeneous: at least 15 distinct genetic subtypes (BBS1 through BBS15) have been identified, each corresponding to mutations in a different BBS gene. These subtypes are clinically very similar but named according to the specific gene involved. The most common subtypes are BBS1 and BBS10, while the rarer subtypes involve genes such as ARL6 (BBS3), BBS4, BBS5, BBS7, BBS8, BBS9, TRIM32 (BBS11), BBS12, MKKS (BBS6), CCDC28B, CEP290, TMEM67, and MKS1 Wikipedia.

Causes of Bardet–Biedl Syndrome

BBS is inherited in an autosomal recessive pattern: an affected individual carries two mutated copies of a BBS gene, one from each parent. The underlying causes are mutations in any one of at least 15 BBS genes:

1. Mutation in BBS1 gene
   BBS1 encodes a core component of the BBSome, a protein complex essential for transporting molecular cargo within cilia. Mutations in BBS1 disrupt ciliary trafficking, leading to the characteristic features of BBS. BBS1 mutations account for about 25% of all cases MedlinePlusWikipedia.

2. Mutation in BBS10 gene
   BBS10 encodes a type II chaperonin crucial for assembling the BBSome complex. Faulty BBS10 impairs BBSome formation and ciliary function, causing multisystem disease. BBS10 mutations make up roughly 20% of cases MedlinePlusWikipedia.

3. Mutation in BBS2 gene
   BBS2 is another structural BBSome protein. Its mutation leads to unstable BBSome assembly and compromised intraflagellar transport within cilia Wikipedia.

4. Mutation in ARL6 (BBS3) gene
   ARL6 encodes a small GTPase that regulates BBSome recruitment to the ciliary membrane. Disruption of ARL6 impairs BBSome docking and ciliary signaling Wikipedia.

5. Mutation in BBS4 gene
   BBS4 interacts with other BBSome components to guide protein movement along cilia. BBS4 mutations compromise this transport and lead to the broad clinical features of BBS Wikipedia.

6. Mutation in BBS5 gene
   BBS5 is involved in anchoring the BBSome to ciliary membranes. Mutations here cause partial BBSome defects and variable disease severity Wikipedia.

7. Mutation in MKKS (BBS6) gene
   MKKS produces a chaperonin-like protein that assists in BBSome assembly. Loss of MKKS function leads to misfolded BBSome complexes and BBS manifestations Wikipedia.

8. Mutation in BBS7 gene
   BBS7 is required for the structural stability of the BBSome. Its mutation results in ciliary protein trafficking errors and multisystem involvement Wikipedia.

9. Mutation in BBS8 (TTC8) gene
   TTC8 (BBS8) supports BBSome surface localization. Defects in TTC8 disrupt cargo transport and ciliary maintenance Wikipedia.

10. Mutation in BBS9 gene
    BBS9 is essential for BBSome integrity. Mutations here weaken the complex and impede normal ciliary function Wikipedia.

11. Mutation in TRIM32 (BBS11) gene
    TRIM32 regulates BBSome stability through ubiquitination. TRIM32 defects lead to accelerated BBSome degradation and clinical BBS Wikipedia.

12. Mutation in BBS12 gene
    BBS12 encodes a vertebrate-specific chaperonin-like protein necessary for BBSome assembly. Its loss impairs ciliary structure and leads to BBS features Wikipedia.

13. Mutation in CCDC28B gene
    CCDC28B modulates BBSome trafficking efficiency. Mutations cause partial BBSome dysfunction and variable expressivity Wikipedia.

14. Mutation in CEP290 gene
    CEP290 encodes a centrosomal protein that interacts with the BBSome. Disruption of CEP290 perturbs ciliary gating and contributes to BBS Wikipedia.

15. Mutation in TMEM67 gene
    TMEM67, also known as MKS3, forms part of the transition zone at the base of cilia. Its mutation disturbs ciliary entry of proteins, resulting in BBS-like features Wikipedia.

Symptoms of Bardet–Biedl Syndrome

BBS features vary widely, but the core ten hallmarks include:

1. Night blindness (nyctalopia)
   Early in childhood, affected individuals struggle to see in low light because photoreceptor cells degenerate MedlinePlusWikipedia.

2. Tunnel vision
   As peripheral retina cells die, blind spots enlarge, progressing to “tunnel” or “tubular” vision over time MedlinePlusWikipedia.

3. Postaxial polydactyly
   Extra fingers or toes appear on the outer side of hands or feet at birth, often requiring surgical removal rarediseases.info.nih.govPediatric Endocrine Society.

4. Central obesity
   Excess weight, particularly around the trunk, begins in infancy and persists due to altered metabolic signaling Wikipediaerknet.org.

5. Hypogonadism
   Low sex hormone production leads to underdeveloped reproductive organs and often infertility in males rarediseases.info.nih.gov.

6. Renal abnormalities
   Structural kidney defects range from cysts to dysplasia, risking chronic kidney disease in up to half of patients MedlinePlusKarger.

7. Learning difficulties
   Many children exhibit mild to moderate cognitive delays, affecting academic achievement and daily living skills rarediseases.info.nih.gov.

8. Speech and language delay
   Delayed onset of speech and articulation problems are common, sometimes requiring speech therapy Wikipedia.

9. Hearing impairment
   Some patients develop sensorineural hearing loss or auditory processing issues, often detected in early childhood Wikipedia.

10. Syndactyly and brachydactyly
    Fusion of digits (syndactyly) or unusually short fingers or toes (brachydactyly) can occur alongside polydactyly Wikipedia.

Diagnostic Tests for Bardet–Biedl Syndrome

Diagnosis combines clinical evaluation with targeted tests. Below are 20 key assessments, organized by category, each explained in simple terms.

Physical Examination

1. Visual acuity testing
Measures clarity of vision using eye charts. Declining results over time signal progressive retinal dystrophy MedlinePlus.

2. Funduscopic (retinal) examination
An ophthalmoscope inspects the retina for signs of pigmentary changes and vessel attenuation EyeWiki.

3. Anthropometric measurements
Recording height, weight, and body mass index (BMI) helps track obesity and growth patterns erknet.org.

4. Blood pressure measurement
Regular checks identify hypertension, which can worsen renal and cardiovascular health Nature.

Manual Tests

5. Rinne test
A tuning fork compares air versus bone conduction of sound to screen for conductive hearing loss Wikipedia.

6. Weber test
A tuning fork on the forehead determines if hearing loss is sensorineural or conductive Wikipedia.

7. Finger-to-nose coordination test
Assesses cerebellar function by having the patient alternately touch their nose and the examiner’s finger Wikipedia.

8. Muscle strength grading
Manual resistance tests evaluate limb muscle power, revealing subtle neurological involvement Wikipedia.

Laboratory and Pathological Tests

9. Serum creatinine
Measures kidney filtration ability; elevated levels indicate reduced renal function erknet.org.

10. Blood urea nitrogen (BUN)
Assesses nitrogen waste in blood; high BUN suggests impaired kidney clearance erknet.org.

11. Fasting blood glucose
Screens for diabetes, a common comorbidity that can accelerate kidney damage and obesity erknet.org.

12. Urinalysis
Examines urine for protein, blood, and concentration defects, flagging early renal pathology Nature.

Electrodiagnostic Tests

13. Full-field electroretinography (ERG)
Measures electrical responses of retinal cells to light flashes, confirming photoreceptor dysfunction Karger.

14. Visual evoked potentials (VEP)
Records brain responses to visual stimuli, assessing integrity of the visual pathway Karger.

15. Nerve conduction studies (NCS)
Evaluate speed of electrical impulses along peripheral nerves, detecting peripheral neuropathy Wikipedia.

16. Auditory brainstem response (ABR)
Assesses hearing and neural transmission by recording electrical waves generated by the brainstem in response to sound Wikipedia.

Imaging Tests

17. Renal ultrasound
Uses sound waves to visualize kidney size, shape, and cysts, guiding management of renal disease Orpha.

18. Optical coherence tomography (OCT)
Provides high-resolution images of retinal layers, detecting early photoreceptor loss EyeWiki.

19. Abdominal MRI or CT scan
Offers detailed views of kidney structure and other abdominal organs for anomalies not seen on ultrasound erknet.org.

20. Echocardiography
Assesses heart structure and function, screening for septal hypertrophy or cardiomyopathy occasionally seen in BBS Nature.

Non-Pharmacological Treatments

A. Exercise Therapies

1. Aerobic Exercise

   • Description: Activities like brisk walking, cycling, or swimming.

   • Purpose: Controls weight gain and improves cardiovascular health.

   • Mechanism: Burns calories and enhances insulin sensitivity by increasing muscle glucose uptake Dove Medical Press.

2. Resistance Training

   • Description: Weight lifting or resistance band routines.

   • Purpose: Builds lean muscle mass and boosts metabolic rate.

   • Mechanism: Stimulates muscle protein synthesis, increasing resting energy expenditure PMC.

3. Flexibility & Stretching

   • Description: Daily routines targeting major muscle groups.

   • Purpose: Improves joint mobility and reduces injury risk during other exercises.

   • Mechanism: Increases muscle and tendon elasticity via repetitive elongation.

4. Balance & Coordination Drills

   • Description: Single-leg stands or stability-ball exercises.

   • Purpose: Addresses mild ataxia and poor coordination in BBS.

   • Mechanism: Enhances proprioception through neuromuscular adaptation.

5. Low-Impact Cardio

   • Description: Elliptical training or water aerobics.

   • Purpose: Reduces joint strain while still promoting cardiovascular fitness.

   • Mechanism: Provides sustained moderate-intensity activity that spares bones and joints.

6. Breathing & Postural Training

   • Description: Diaphragmatic breathing and posture exercises.

   • Purpose: Supports respiratory function, especially if kidney or liver enlargement affects breathing.

   • Mechanism: Enhances diaphragm mobility and thoracic expansion.

7. Home Exercise Program (HEP)

   • Description: Tailored routines patients can do unsupervised.

   • Purpose: Ensures consistency in therapy when clinic visits are infrequent.

   • Mechanism: Reinforces learned movements, promoting neural plasticity and strength retention jmpas.com.

8. Physical Therapy

   • Description: Therapist-guided sessions for gross motor skills.

   • Purpose: Improves gait mechanics and posture.

   • Mechanism: Uses task-specific training to rewire neuromuscular pathways.

9. Occupational Therapy

   • Description: Activities of daily living (ADL) training.

   • Purpose: Enhances independence in self-care and fine motor tasks.

   • Mechanism: Breaks complex tasks into achievable steps, reinforcing motor planning.

10. Visual Rehabilitation Exercises

• Description: Light-sensitivity training and contrast drills.

• Purpose: Maximizes remaining visual function in retinal dystrophy.

• Mechanism: Encourages neuro-optic adaptation to low-vision environments.

B. Mind-Body Treatments

11. Mindfulness Meditation

    • Description: Guided breath or body-scan practices.

    • Purpose: Reduces stress, which can exacerbate eating behaviors.

    • Mechanism: Lowers cortisol, improving appetite control centers in the brain.

12. Yoga Therapy

    • Description: Gentle asanas with breathing focus.

    • Purpose: Enhances flexibility, balance, and mental well-being.

    • Mechanism: Combines isometric holds with parasympathetic activation to reduce hyperphagia.

13. Cognitive-Behavioral Techniques

    • Description: Guided journaling and thought-restructuring exercises.

    • Purpose: Addresses compulsive eating and emotional dysregulation.

    • Mechanism: Teaches patients to identify and reframe maladaptive thought patterns.

14. Guided Imagery

    • Description: Visualization of healthy behaviors.

    • Purpose: Motivates adherence to lifestyle changes.

    • Mechanism: Activates brain regions involved in motor planning and self-efficacy.

15. Biofeedback

    • Description: Real-time monitoring of physiological signals (e.g., heart rate).

    • Purpose: Helps patients gain conscious control over stress responses.

    • Mechanism: Teaches regulation of autonomic functions to reduce anxiety and overeating.

C. Educational Self-Management

16. Nutrition Education

    • Description: Counseling on macronutrient balance and portion sizes.

    • Purpose: Empowers healthier meal choices to control weight and support kidney health.

    • Mechanism: Uses goal-setting and meal planning to change eating habits.

17. Family Involvement Programs

    • Description: Workshops for caregivers on supportive behaviors.

    • Purpose: Ensures consistent home environment for dietary and exercise plans.

    • Mechanism: Builds a positive feedback loop through shared accountability Nature.

18. Peer Support Groups

    • Description: Regular meetings with other families affected by BBS.

    • Purpose: Reduces isolation and shares practical coping strategies.

    • Mechanism: Leverages social learning to reinforce adaptive behaviors.

19. Symptom-Tracking Journals

    • Description: Daily logs of vision, appetite, energy, and mood.

    • Purpose: Identifies triggers and patterns for tailored interventions.

    • Mechanism: Increases self-awareness and prompts timely adjustments in management.

20. Tele-health Check-Ins

    • Description: Virtual consultations to review progress.

    • Purpose: Maintains continuity of care between clinic visits.

    • Mechanism: Uses digital platforms to share data and reinforce adherence.

---

Evidence-Based Pharmacological Treatments

1. Setmelanotide (Imcivree)

   • Class: Melanocortin-4 receptor agonist

   • Dosage: 1–3 mg subcutaneous daily, adjusted by weight

   • Timing: Once daily, morning preferred

   • Side Effects: Injection site reactions, nausea, headache U.S. Food and Drug Administration.

2. Metformin

   • Class: Biguanide

   • Dosage: 500 mg twice daily, may escalate to 2 g/day

   • Timing: With meals

   • Side Effects: Gastrointestinal upset, lactic acidosis (rare).

3. ACE Inhibitors (e.g., Lisinopril)

   • Class: ACE inhibitor

   • Dosage: 5–20 mg daily

   • Timing: Morning

   • Side Effects: Cough, hyperkalemia, hypotension.

4. Angiotensin II Receptor Blockers (e.g., Losartan)

   • Class: ARB

   • Dosage: 50–100 mg daily

   • Timing: Morning

   • Side Effects: Dizziness, hyperkalemia.

5. Statins (e.g., Atorvastatin)

   • Class: HMG-CoA reductase inhibitor

   • Dosage: 10–20 mg nightly

   • Timing: Evening

   • Side Effects: Myalgia, elevated liver enzymes.

6. Beta-Blockers (e.g., Metoprolol)

   • Class: β₁-selective blocker

   • Dosage: 25–100 mg twice daily

   • Timing: Morning and afternoon

   • Side Effects: Fatigue, bradycardia.

7. Vitamin A Palmitate

   • Class: Retinoid

   • Dosage: 15,000 IU/day for retinal support

   • Timing: With meal (fat enhances absorption)

   • Side Effects: Headache, nausea, teratogenic risk Healthline.

8. Erythropoietin Stimulating Agents

   • Class: ESA

   • Dosage: 50–100 IU/kg subcutaneous 3× weekly

   • Timing: As directed by hemoglobin levels

   • Side Effects: Hypertension, thrombosis risk.

9. Potassium Citrate

   • Class: Urinary alkalinizer

   • Dosage: 10–20 mEq 3× daily

   • Timing: With meals

   • Side Effects: GI discomfort, hyperkalemia.

10. Proton Pump Inhibitors (e.g., Omeprazole)

    • Class: PPI

    • Dosage: 20 mg daily

    • Timing: Morning before breakfast

    • Side Effects: Headache, diarrhea.

---

Dietary Molecular Supplements

1. Lutein (6 mg/day)

   • Function: Macular pigment support

   • Mechanism: Filters blue light, antioxidant action Wikipedia.

2. Zeaxanthin (2 mg/day)

   • Function: Central vision protection

   • Mechanism: Quenches reactive oxygen species Verywell Health.

3. Omega-3 Fatty Acids (EPA/DHA 1 g/day)

   • Function: Anti-inflammatory, cardiovascular support

   • Mechanism: Modulates eicosanoid pathways.

4. Coenzyme Q10 (100 mg/day)

   • Function: Mitochondrial support

   • Mechanism: Electron carrier in respiratory chain.

5. Vitamin D₃ (2000 IU/day)

   • Function: Bone and immune health

   • Mechanism: Regulates calcium absorption.

6. Magnesium Citrate (300 mg/day)

   • Function: Muscle and nerve function

   • Mechanism: Cofactor for ATP-dependent enzymes.

7. N-Acetylcysteine (600 mg twice daily)

   • Function: Antioxidant precursor

   • Mechanism: Boosts glutathione synthesis.

8. L-Carnitine (500 mg twice daily)

   • Function: Fatty acid transport

   • Mechanism: Shuttles long-chain fatty acids into mitochondria.

9. Creatine Monohydrate (3 g/day)

   • Function: Muscle energy buffer

   • Mechanism: Recharges ATP during high-intensity activity.

10. Alpha-Lipoic Acid (300 mg/day)

    • Function: Neuroprotection

    • Mechanism: Regenerates other antioxidants.

---

 Advanced Drug Therapies

1. Zoledronic Acid (Bisphosphonate)

   • Dosage: 5 mg IV once yearly

   • Function: Improves bone density

   • Mechanism: Inhibits osteoclast-mediated bone resorption.

2. Teriparatide (Regenerative)

   • Dosage: 20 µg subcutaneous daily

   • Function: Stimulates bone formation

   • Mechanism: PTH analog that activates osteoblasts.

3. Hyaluronic Acid Injections (Viscosupplementation)

   • Dosage: 20 mg intra-articular weekly × 3

   • Function: Joint lubrication

   • Mechanism: Restores synovial fluid viscosity.

4. Mesenchymal Stem Cell Therapy

   • Dosage: 1–2×10⁶ cells/kg IV infusion

   • Function: Supports tissue repair

   • Mechanism: Paracrine secretion of growth factors.

5. Platelet-Rich Plasma (Regenerative)

   • Dosage: 3–5 mL intra-lesional single dose

   • Function: Accelerates healing

   • Mechanism: Releases cytokines and growth factors.

6. Exosome-Based Treatments

   • Dosage: Under investigation

   • Function: Cell-to-cell signaling for regeneration

   • Mechanism: Delivers miRNA and proteins to target cells.

---

Surgical Interventions

1. Polydactyly Correction

   • Procedure: Excision of extra digit under tourniquet anesthesia.

   • Benefit: Improves hand/foot function and cosmesis.

2. Retinal Prosthesis Implantation

   • Procedure: Electronic chip placement on retina.

   • Benefit: Restores partial vision in end-stage retinal dystrophy.

3. Renal Transplantation

   • Procedure: Allograft of healthy kidney.

   • Benefit: Replaces non-functional kidneys, halts dialysis.

4. Bariatric Surgery (e.g., Sleeve Gastrectomy)

   • Procedure: Resection of part of the stomach.

   • Benefit: Sustained weight loss in morbid obesity.

5. Gonadoplasty

   • Procedure: Reconstruction of genital anomalies.

   • Benefit: Normalizes anatomy, improves function and psychosocial well-being.

---

Prevention Strategies

1. Early Genetic Counseling

   • Identifies carrier status and informs family planning.

2. Newborn Screening in High-Risk Populations

   • Enables prompt intervention for vision and kidney issues.

3. Regular Ophthalmic Exams

   • Detects and manages retinal changes before advanced vision loss.

4. Routine Renal Ultrasound

   • Monitors kidney structure to prevent end-stage damage.

5. Blood Pressure Monitoring

   • Controls hypertension to protect renal function.

6. Nutritional Counseling

   • Prevents excessive weight gain and metabolic complications.

7. Vision Rehabilitation Services

   • Teaches adaptation strategies early to maximize independence.

8. Physical Activity Guidelines

   • Reduces sedentary time to mitigate obesity risks.

9. Sun Protection for Eyes

   • Uses UV-blocking sunglasses to slow retinal damage.

10. Immunizations

    • Protects against infections that could strain kidneys or heart.

---

When to See a Doctor

Seek medical attention promptly if any of the following occur:

• Sudden vision changes (e.g., flashes, rapid decline).

• New-onset or worsening edema, fatigue, or decreased urine output (signs of kidney decline).

• Uncontrolled weight gain despite diet and exercise.

• Persistent high blood pressure.

• Severe joint pain unresponsive to conservative measures.

• Developmental plateaus or new behavioral concerns.

• Signs of hypogonadism (e.g., delayed puberty).

• Recurrent urinary tract infections.

• Any surgical site complications (e.g., infection).

• Concerns about genetic risks for future children.

---

“What to Do” and “What to Avoid”

1. Do follow a heart- and kidney-friendly diet; Avoid high-salt, high-protein excess.

2. Do engage in regular, tailored exercise; Avoid prolonged sedentary periods.

3. Do schedule annual ophthalmology and nephrology visits; Avoid skipping follow-ups.

4. Do use low-vision aids; Avoid bright glare without protective eyewear.

5. Do take prescribed medications on schedule; Avoid self-adjusting doses.

6. Do prioritize sleep hygiene; Avoid stimulants late in the day.

7. Do involve family in care plans; Avoid isolating lifestyle.

8. Do maintain a symptom diary; Avoid passive symptom neglect.

9. Do keep up-to-date with genetic research; Avoid unproven supplements.

10. Do seek mental health support; Avoid ignoring stress or depression.

---

Frequently Asked Questions

1. What causes BBS?
   BBS arises from autosomal-recessive mutations in any of at least 24 BBS genes, disrupting the BBSome ciliary complex and leading to multisystem disease Wikipedia.

2. Is there a cure?
   No cure exists; management focuses on symptom-based therapies to preserve vision, kidney function, and overall quality of life.

3. What is the life expectancy?
   Varies widely; kidney failure can shorten lifespan, but with timely renal replacement therapy many live into adulthood.

4. Can diet prevent complications?
   A balanced, calorie-controlled diet helps mitigate obesity-related comorbidities but cannot reverse genetic defects.

5. Is obesity reversible?
   Lifestyle measures and drugs like setmelanotide can achieve significant weight loss; bariatric surgery is an option for severe cases.

6. How is vision loss managed?
   Low-vision aids, orientation and mobility training, and—when eligible—retinal prosthesis may help maintain functional vision.

7. When should children be screened?
   Early screening at birth for polydactyly and eye exams by age one facilitates prompt supportive interventions.

8. Does BBS affect intelligence?
   There can be mild to moderate learning difficulties; early educational support improves cognitive outcomes.

9. Can BBS recur in families?
   Each child of two carriers has a 25% risk; genetic counseling is recommended for family planning.

10. Are there clinical trials?
    Yes, ongoing trials investigate gene therapy, ciliopathy-targeted drugs, and stem cell approaches.

11. Is growth hormone therapy used?
    Rarely; short stature in BBS is less pronounced than in related syndromes and GH lacks robust evidence.

12. How often should renal function be tested?
    At least annually, or more frequently if signs of decline emerge.

13. Can vision rehabilitation slow progression?
    While it doesn’t alter degeneration, it maximizes residual vision and functional independence.

14. Are there support networks?
    Yes; BBS Foundations and peer groups provide resources and community support.

15. What research is promising?
    Gene editing (CRISPR/Cas9) and BBSome-stabilizing small molecules show early potential in preclinical models.

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: July 14, 2025.